Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Web Exclusives

Ilixadencel Gets Orphan Drug Designation for Soft Tissue Sarcoma

Ilixadencel Gets Orphan Drug Designation for Soft Tissue Sarcoma

BY KRISTI ROSA

FDA Grants Toripalimab Fast Track Status for Mucosal Melanoma

FDA Grants Toripalimab Fast Track Status for Mucosal Melanoma

BY KRISTI ROSA

1 in 5 Patients Engage in Nonmedical Opioid Use

1 in 5 Patients Engage in Nonmedical Opioid Use

BY BRIELLE BENYON

Lung-Sparing Nodule Resection Needs Multidisciplinary Approach in Lung Cancer

Lung-Sparing Nodule Resection Needs Multidisciplinary Approach in Lung Cancer

BY JESSICA HERGERT

Immunotherapy May Highlight Neoadjuvant Treatment's Use in Lung Cancer

Immunotherapy May Highlight Neoadjuvant Treatment's Use in Lung Cancer

BY CAROLINE SEYMOUR

Retifanlimab Granted Priority Review for Squamous Cell Carcinoma of the Anal Canal

Retifanlimab Granted Priority Review for Squamous Cell Carcinoma of the Anal Canal

BY KRISTI ROSA

FDA Approves Cabozantinib Plus Nivolumab for Frontline Advanced RCC

FDA Approves Cabozantinib Plus Nivolumab for Frontline Advanced RCC

BY BRIELLE BENYON

COVID-19 Vaccine for Patients With Cancer: NCCN Guidance

COVID-19 Vaccine for Patients With Cancer: NCCN Guidance

BY BRIELLE BENYON

Aspirin May Offer Survival Advantage in Breast, Bladder Cancer

Aspirin May Offer Survival Advantage in Breast, Bladder Cancer

BY BRIELLE BENYON

Maintain COVID-19 Precautions After Vaccine Distribution

Maintain COVID-19 Precautions After Vaccine Distribution

BY BRIELLE BENYON

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.